Transparent Face Masks for Respiratory Protection

Recruiting in Palo Alto (17 mi)

Overseen ByPeter Chai, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Brigham and Women's Hospital

No Placebo Group

Trial Summary

What is the purpose of this trial?Face masks have become a critically important public health intervention after the COVID-19 pandemic. Multiple types of masks ranging from full face filtering to cloth masks have been developed and commercialized to facilitate protection against respiratory pathogens. Most of these systems are made with opaque fabrics and may prevent individuals from expressing emotions or for those who are deaf and hard of hearing, communicating. To date, few transparent face masks which also confer respiratory pathogen protection have been developed. This study will test the feasability and acceptability of two new masks, the SEEUS-95 mask and CrystalGuard mask which are both transparent versions of N-95 filtering face masks.

Eligibility Criteria

This trial is for individuals who are interested in testing the feasibility and acceptability of two new transparent face masks designed to protect against respiratory pathogens like COVID-19. Specific eligibility criteria were not provided.

Inclusion Criteria

I am over 18 years old.

I have never had asthma or serious lung diseases.

Exclusion Criteria

I am under 18 years old.

Participant Groups

The study is comparing the traditional N95 face mask with two novel transparent masks: CrystalGuard Mask and SEEUS95 Transparent mask, to assess their effectiveness and user experience.

3Treatment groups

Experimental Treatment

Active Control

Group I: SEEUS95Experimental Treatment1 Intervention

Transparent mask developed by SEEUS95

Group II: CrystalGuardExperimental Treatment1 Intervention

Transparent mask developed at BWH

Group III: N95Active Control1 Intervention

Standard N95 face mask